Neurocrine Biosciences Inc. | TalkMarkets

Latest Posts

Five Best And Worst Performing Healthcare Stocks In January 2023

Article By: ValueWalk

Sunday, February 5, 2023 1:40 PM EDT

After a sub-par performance in 2021, healthcare stocks outperformed the S&P 500 in 2022. As well, 2023 is expected to be another promising year for the sector. Let’s take a look at the five best and worst performing healthcare stocks in January 2023.

In this article: BAX, CNC, PFE, ALGN, IDXX, NBIX, EXAS, ABBV, BGNE, GEHC

Read

The Week Ahead In Biotech: Avenue's FDA Decision, Alkermes Adcom Meeting, Aziyo Biologics IPO

Article By: Benzinga

Sunday, October 4, 2020 4:24 PM EDT

Biotech stocks made a steady recovery over the week ended October 2, although Friday's weakness trimmed some of the gains of the week. Companies working on anti-COVID-19 antibody treatments were in the news during the week.

In this article: SRNE, REGN, ALKS, NBIX, MESO, SELB, FBIO, ZSAN, ETON, ATXI

Read

What’s Next For The Biotech Bull Market? Are You A Trader Or An Investor?

Article By: Rod Raynovich

Tuesday, May 26, 2020 1:57 AM EDT

Despite the economic pains of the pandemic, investors are driven to life science companies in the news with potential solutions for COVID-19. The potential for a COVID-19 vaccine or a new viral diagnostic product has been the focus of the market.

In this article: BMY, MRK, RHHBY, FBIOX, IBB, ILMN, INCY, QQQ, REGN, SGEN, GILD, NBIX, PACB, VRTX, AMRN, GDX, XBI, XNCR, TDOC, EDIT, NTLA, CRSP, VIR, ABBV, PRHSX, IDXX

Read

Biotech Stocks Mixed But Outperform The Market On A Down Day

Article By: Rod Raynovich

Saturday, February 22, 2020 11:58 PM EDT

Biotech stocks were mixed but outperformed the market perhaps on the belief that they have the potential of a cure with antiviral therapies and vaccines.

In this article: BMRN, IBB, REGN, GILD, NBIX, XBI, XLK, XLV, ICPT

Read